New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2014
06:10 EDTRAREUltragenyx Pharmaceuticals 5.76M share IPO priced at $21.00
The deal size was increased to 5.76M shares from 4.83M shares and priced above the $19.00-$20.00 range. JPMorgan and Morgan Stanley acted as joint book running managers for the offering.
News For RARE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 27, 2015
10:00 EDTRAREOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:21 EDTRAREOn The Fly: Pre-market Movers
HIGHER: Magnetek (MAG), up 53.5% after Columbus McKinnon (CMCO) agrees to acquire the company... Xueda Education (XUE), up 40.6% after merging with Xiamen Insight Investment... Box (BOX), up 4.6% after being upgraded to Overweight from Sector Weight at Pacific Crest... Goodrich Petroleum (GDP), up 6.4% after announcing sale of proved reserves and a portion of Eagle Ford leasehold. NOTABLE: Teva Pharmaceutical (TEVA), up 10.7% after acquiring Allergan Generics... Allergan (AGN) is up 6.3%... Mylan (MYL), down 14% after Teva withdraws proposal to acquire the company... Perrigo (PRGO), up 3% after Teva withdraws proposal to acquire Mylan. DOWN AFTER EARNINGS: Sohu.com (SOHU), down 6%... Changyou.com (CYOU), down 10.1%. ALSO LOWER: Bellerophon (BLPH) down 63% after announcing results of BCM clinical trial... Terex (TEX), down 4% after being downgraded to Sell from Neutral at Goldman... Ultragenyx Pharmaceutical (RARE), down 3.5% after being downgraded to Equal Weight from Overweight at Morgan Stanley...
07:17 EDTRAREUltragenyx downgraded to Equal Weight from Overweight at Morgan Stanley
Subscribe for More Information
05:55 EDTRAREUltragenyx downgraded to Equal Weight from Overweight at Morgan Stanley
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use